Prediction in breast cancer of the extent of axillary node involvement from the size and lymphovascular invasion status of the primary tumour: medico-legal considerations.
AIM: To ascertain for medico-legal purposes in the United Kingdom, the extent to which in breast cancer primary tumour size and lympho-vascular invasion (LVI) status determine axillary node staging. METHODS: Four hundred and fifty symptomatic patients had their tumour sizes stratified into 1cm ranges and the percentage incidence/probability of the axillary stage being 1, 2 or 3 was calculated separately for those tumours that showed no evidence of LVI and those that did. RESULTS: The presence of LVI has a marked effect on the likelihood and extent of axillary node involvement for all primary tumour sizes. CONCLUSIONS: This needs to be recognized and quantified when prediction of this extent is made for medico-legal purposes. Within the constraints of the 'balance of probabilities' argument in UK law, it is rarely possible to differentiate between the likelihood of the axillary stage being 2 or 3.